Hyoscyamine er (hyoscyamine sulfate)

Hyoscyamine er (hyoscyamine sulfate) is filed as Belladonna alkaloids, tertiary amines. The sections below restate public label fields stored for this profile.

Class
Belladonna alkaloids, tertiary amines
Generic name
hyoscyamine sulfate
Route
ORAL
Dosage forms
HOW SUPPLIED Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg are white, capsule-shaped tablets. They are coded “AP” on one side and “115” on the other. Bottles of 100 tablets NDC 75929-057-10 Store at controlled room temperature 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F). Please refer to current USP. Dispense in tight, light-resistant containers as defined in USP/NF with a child-resistant closure. KEEP OUT OF REACH OF CHILDREN Also available as: Dosage Strength Package Size NDC Hyoscyamine Sulfate Tablets, USP 0.125 mg 100 75929-055-10 Hyoscyamine Sulfate Sublingual Tablets 0.125 mg 100 75929-056-10 Distributed by: Wallace Pharmaceuticals Inc. Somerset, New Jersey 08873-4120 ©2018 Mylan Pharmaceuticals Inc WALLACE and are trademarks of Wallace Pharmaceuticals Inc., a Mylan company IN-1151-03 Rev. 3/2018 Printed in USA 70011278 Wallace Pharmaceuticals Inc. Logo
Manufacturer
Pharma Packaging Solutions, LLC dba Tjopack LLC

Approved uses

INDICATIONS AND USAGE Hyoscyamine sulfate extended-release tablets are effective as adjunctive therapy in the treatment of peptic ulcer. They can also be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps. May be used in functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis, and acute enterocolitis. For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. Also used as adjunctive therapy in the treatment of neurogenic bladder andmneurogenic bowel disturbances (including the splenic flexure syndrome and neurogenic colon). Hyoscyamine sulfate extended-release tablets are indicated along with morphine or other narcotics in symptomatic relief of biliary and renal colic; as a “drying agent” in the relief of symptoms of acute rhinitis; in the therapy of parkinsonism to reduce rigidity and tremors and to control associated sialorrhea and hyperhidrosis. May be used in the therapy of poisoning by anticholinesterase agents.

How it works

CLINICAL PHARMACOLOGY Hyoscyamine sulfate inhibits specifically the actions of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic receptors are present in the autonomic effector cells of the smooth muscle, the cardiac muscle, the sinoatrial node, the atrioventricular node, and the exocrine glands. At therapeutic doses, it is completely devoid of any action on autonomic ganglia. Hyoscyamine sulfate inhibits gastrointestinal propulsive motility and decreases gastric acid secretion. Hyoscyamine sulfate also controls excessive pharyngeal, tracheal, and bronchial secretions. Hyoscyamine sulfate is absorbed totally and completely by oral administration. Once absorbed, hyoscyamine sulfate disappears rapidly from the blood and is distributed throughout the entire body: the half-life of hyoscyamine sulfate is 2 to 3½ hours. Hyoscyamine sulfate is partly hydrolyzed to tropic acid and tropine but the majority of the drug is excreted in the urine unchanged within the first 12 hours. Only traces of this drug are found in breast milk. Hyoscyamine sulfate passes the blood brain barrier and the placental barrier. Hyoscyamine sulfate extended-release tablets releases 0.375 mg hyoscyamine sulfate at a controlled and predictable rate for 12 hours. The mean peak plasma concentration occurred at 4.20 hours. The mean (±SEM) apparent plasma elimination half-life is 7.47 hours (±0.60). Tablets may not completely disintegrate and may be excreted by some patients.

Warnings and precautions

WARNINGS In the presence of high environmental temperature, heat prostration can occur with drug use (fever and heat stroke due to decreased sweating). Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy. In this instance, treatment with this drug would be inappropriate and possibly harmful. Like other anticholinergic agents, hyoscyamine sulfate may produce drowsiness, dizziness, or blurred vision. In this event, the patient should be warned not to engage in activities requiring mental alertness such as operating a motor vehicle or other machinery or to perform hazardous work while taking this drug. Psychosis has been reported in sensitive individuals given anticholinergic drugs including hyoscyamine sulfate. CNS signs and symptoms include confusion, disorientation, short-term memory loss, hallucinations, dysarthria, ataxia, euphoria, anxiety, fatigue, insomnia, agitation and mannerisms, and inappropriate affect. These CNS signs and symptoms usually resolve within 12 to 48 hours after discontinuation of the drug.

Contraindications

CONTRAINDICATIONS Glaucoma; obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis); paralytic ileus, intestinal atony of elderly or debilitated patients; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; myasthenia gravis.

Dosage and administration

DOSAGE AND ADMINISTRATION Dosage may be adjusted according to the conditions and severity of symptoms. Adults And Pediatric Patients 12 Years Of Age And Older 1 to 2 tablets every 12 hours. Do not crush or chew tablets. Do not exceed 4 tablets in 24 hours.

Drug interactions

Drug Interactions Additive adverse effects resulting from cholinergic blockade may occur when hyoscyamine sulfate is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines. Antacids may interfere with the absorption of hyoscyamine sulfate.

Common questions

What is Hyoscyamine er approved to treat?

According to its FDA label, Hyoscyamine er (hyoscyamine sulfate) is approved for: INDICATIONS AND USAGE Hyoscyamine sulfate extended-release tablets are effective as adjunctive therapy in the treatment of peptic ulcer. They can also be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm… For medical advice, please talk to your prescriber or pharmacist.

What class of drug is Hyoscyamine er?

Hyoscyamine er (hyoscyamine sulfate) belongs to the Belladonna alkaloids, tertiary amines class of medications.

What form does Hyoscyamine er come in?

The FDA label lists Hyoscyamine er (hyoscyamine sulfate) as: HOW SUPPLIED Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg are white, capsule-shaped tablets. They are coded “AP” on one side and “115” on the other. Bottles of 100 tablets NDC 75929-057-10 Store at controlled room temperature 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F). Please refer to current USP. Dispense in tight, light-resistant containers as defined in USP/NF with a child-resistant closure. KEEP OUT OF REACH OF CHILDREN Also available as: Dosage Strength Package Size NDC Hyoscyamine Sulfate Tablets, USP 0.125 mg 100 75929-055-10 Hyoscyamine Sulfate Sublingual Tablets 0.125 mg 100 75929-056-10 Distributed by: Wallace Pharmaceuticals Inc. Somerset, New Jersey 08873-4120 ©2018 Mylan Pharmaceuticals Inc WALLACE and are trademarks of Wallace Pharmaceuticals Inc., a Mylan company IN-1151-03 Rev. 3/2018 Printed in USA 70011278 Wallace Pharmaceuticals Inc. Logo; oral route. Available strengths and packaging vary by manufacturer.

Does Hyoscyamine er have a Boxed Warning?

Our ingest of the FDA label for Hyoscyamine er (hyoscyamine sulfate) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

How much does Hyoscyamine er cost?

Public CMS NADAC pricing for Hyoscyamine er (hyoscyamine sulfate) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.

Is Hyoscyamine er currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Hyoscyamine er (hyoscyamine sulfate) in our latest ingest. Recall data can change daily — verify at FDA.gov.

Who makes Hyoscyamine er?

The FDA label lists Pharma Packaging Solutions, LLC dba Tjopack LLC as a labeler/manufacturer of Hyoscyamine er (hyoscyamine sulfate). Multiple firms may market generics of the same molecule.

How should Hyoscyamine er be stored?

The FDA label states: "Hyoscyamine Sulfate SLis supplied as round, green, peppermint flavored tablets with "39" debossed on one side. They are available in bottles of 30 tablets, NDC 72189-666-30." Follow the packaging insert for the authoritative guidance.

What is the pregnancy category for Hyoscyamine er?

The FDA label lists a pregnancy category of C for Hyoscyamine er (hyoscyamine sulfate). Pregnancy and lactation decisions should be made with a clinician.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…